UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ☒ | Definitive Proxy Statement | |
| ☐ | Definitive Additional Materials | |
| ☐ | Soliciting Material Pursuant to §240.14a-12 | |
CREDIT SUISSE ASSET MANAGEMENT INCOME FUND, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. | |||
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
| (1) |
Title of each class of securities to which transaction applies:
|
|||
| (2) |
Aggregate number of securities to which transaction applies:
|
|||
| (3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|||
| (4) |
Proposed maximum aggregate value of transaction:
|
|||
| (5) |
Total fee paid:
|
|||
| ☐ | Fee paid previously with preliminary materials. | |||
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
| (1) |
Amount Previously Paid:
|
|||
| (2) |
Form, Schedule or Registration Statement No.:
|
|||
| (3) |
Filing Party:
|
|||
| (4) |
Date Filed:
|
|||
CREDIT SUISSE ASSET MANAGEMENT
INCOME FUND, INC.
Eleven Madison Avenue
New York, New York 10010
(800) 293-1232
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
To Be Held on April22, 2025
T O T HE S HAREHOLDERS O F
C REDIT S UISSE A SSET M ANAGEMENT I NCOME F UND , I NC .:
NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders (the “Meeting”) of Credit Suisse Asset Management Income Fund, Inc. (NYSE American: CIK) (the “Fund” or “CIK”) will be held at the offices of UBS Asset Management (Americas) LLC (“UBS AM (Americas)”), Eleven Madison Avenue (between East 24th and 25th Streets), Floor 2B, New York, New York 10010, on Tuesday, April22, 2025, commencing at 2:00 p.m. Eastern Time.
The purpose of the Meeting is to consider and act upon the following proposal and to consider and act upon such other matters as may properly come before the Meeting or any adjournments thereof:
(1) To elect three (3) Directors of the Fund.
This proposal is discussed in greater detail in the attached Proxy Statement. The Board of Directors of the Fund has determined that it is in the best interest of shareholders and the Fund to vote “FOR” the proposal.
The close of business on March13, 2025 has been fixed as the record date (the “Record Date”) for the determination of the shareholders of the Fund entitled to notice of, and to vote at, the Meeting.
This notice and related proxy materials are first being mailed to shareholders on or about March20, 2025.
By order of the Board of Directors,
O MAR T ARIQ
Chief Executive Officer and President
WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, IT IS IMPORTANT THAT YOUR SHARES BE REPRESENTED AND VOTED AT THE MEETING. ACCORDINGLY, PLEASE DATE, SIGN AND RETURN THE ENCLOSED PROXY CARD PROMPTLY. NO POSTAGE IS REQUIRED IF MAILED IN THE UNITED STATES. IT IS IMPORTANT THAT YOUR PROXY CARD BE RETURNED PROMPTLY IN ORDER TO AVOID THE ADDITIONAL EXPENSE OF FURTHER SOLICITATION.
Dated: March20, 2025
New York, New York
CREDIT SUISSE ASSET MANAGEMENT INCOME FUND, INC.
Eleven Madison Avenue
New York, New York 10010
Proxy Statement for the
Annual Meeting of Shareholders
To Be Held on Tuesday, April22, 2025
This Proxy Statement is furnished in connection with a solicitation of proxies by the Board of Directors (the “Board” and each member thereof, a “Director”), of Credit Suisse Asset Management Income Fund, Inc. (the “Fund”) for use at the Annual Meeting of Shareholders of the Fund to be held at the offices of UBS Asset Management (Americas) LLC (“UBS AM (Americas)”), Eleven Madison Avenue (between East 24th and 25th Streets), Floor2B, New York, New York 10010 on Tuesday, April22, 2025 (commencing at 2:00p.m. Eastern Time) and at any adjournments thereof (collectively, the “Meeting”). A Notice of Annual Meeting of Shareholders and a proxy card (the “Proxy”) accompany this Proxy Statement.
Proxy solicitations will be made primarily by mail, but solicitations may also be made by telephone or personal interviews conducted by officers or employees of the Fund; UBS AM (Americas), the investment adviser to the Fund; State Street Bank and Trust Company, the administrator of the Fund (the “Administrator”); or EQ Fund Solutions, LLC (“EQ”), a professional proxy solicitation firm that has been retained by the Fund for a fee not to exceed $1,500 plus all reasonable out of pocket expenses (mailings, emails, and shareholder telephone calls) incurred on behalf of the Fund. All costs of solicitation, including (a)printing and mailing of this Proxy Statement and accompanying material, (b)the reimbursement of brokerage firms and proxy solicitation firms for their expenses in forwarding solicitation material to the beneficial owners of the Fund’s shares, (c)payment of EQ for its services in soliciting Proxies and (d)supplementary solicitations to submit Proxies, will be borne by the Fund. This Proxy Statement and accompanying Proxy are expected to be mailed to shareholders on or about March20, 2025.
The principal executive office of the Fund and UBS AM (Americas) is 787Seventh Avenue, New York, New York 10019. The principal executive office of the Administrator is One Lincoln Street, Boston, Massachusetts 02111.
The Fund’s Annual Report containing audited financial statements for the fiscal year ended December31, 2024 has previously been furnished to all shareholders of the Fund. The Fund’s Annual Report is not to be regarded as proxy-soliciting material.
If the enclosed Proxy is properly executed and returned in time to be voted at the Meeting, the shares represented thereby will be voted in accordance with the
1
instructions marked on the Proxy. If no instructions are marked on the Proxy, the Proxy will be voted “FOR” the proposal presented for approval at the Meeting and will be voted on any matters that may properly come before the Meeting in accordance with the judgment of the persons named in the Proxy. Any shareholder giving a Proxy has the power to revoke it by mail (addressed to the Secretary of the Fund, c/o UBS Asset Management (Americas) LLC, Eleven Madison Avenue, 9thFloor, New York, New York 10010), voting again through the toll-free number or the Internet address listed in the Proxy or at the Meeting by executing a superseding Proxy or by submitting a notice of revocation. Merely attending the Meeting, however, will not revoke any previously submitted Proxy.
A quorum of shareholders is constituted by the presence at the virtual meeting or by proxy of the holders of one-third of the outstanding shares of the Fund entitled to vote at the Meeting. In the event that a quorum is not present at the Meeting, the holders of a majority of the shares present in person or by proxy or the Chairman of the Meeting will have the power to adjourn the Meeting, without notice other than an announcement at the Meeting, until the requisite number of shares entitled to vote at the Meeting is present. In the event that a quorum is present at the Meeting but sufficient votes to approve any proposal are not received, the Meeting may be adjourned by the Chairman of the Meeting or the shareholders may propose an adjournment of the Meeting to permit further solicitation of Proxies. Any such adjournment by the shareholders will require the affirmative vote of a majority of the Fund’s shares represented at the Meeting in person or by proxy, and the persons named as proxies will vote those Proxies that they are entitled to vote “FOR” any proposal in favor of such adjournment and will vote those proxies required to be voted “AGAINST” any proposal against any such adjournment. Absent the establishment of a subsequent record date and the giving of notice to the holders of record thereon, the adjourned Meeting must take place not more than 120days after the record date. At such adjourned Meeting, any business may be transacted which might have been transacted at the original Meeting. If a quorum is present, a shareholder vote may be taken on a proposal properly brought before the Meeting prior to any adjournment if sufficient votes have been received and it is otherwise appropriate.
For purposes of determining the presence of a quorum for transacting business at the Meeting, abstentions and broker “non-votes” (that is, proxies from brokers or nominees indicating that such persons have not received instructions from the beneficial owner or other persons entitled to vote shares on a particular matter with respect to which the brokers or nominees do not have discretionary power) will be treated as shares that are present at the Meeting but which have not been voted. Accordingly, shareholders are urged to forward their voting instructions promptly.
The election of a Director will require that the candidate receive a plurality of the votes cast at the Meeting virtually or by proxy. A “plurality” vote means the candidate who receives the largest number of votes cast (even if they receive less than a majority) will be elected as a Director. Since each candidate for election as a
2
Director is running unopposed, each candidate only needs one vote to be elected if there is a quorum present at the Meeting. Because abstentions and broker non-votes are not treated as shares voted, any abstentions and broker non-votes would have no impact on the election.
UBS AM (Americas) and its affiliates have advised the Fund that they intend to vote the shares over which they have voting power at the Meeting, including shares that are held directly or on behalf of employees, in the manner instructed by the customers or employees for which such shares are held.
The Fund has one class of shares of capital stock, par value $0.001 per share (the “Shares”). On the record date, March13, 2025, there were 54,812,003 Shares outstanding. Each Share is entitled to one vote at the Meeting, and fractional Shares are entitled to a proportionate share of one vote. In accordance with the rules of the Securities and Exchange Commission (“SEC”), the Fund is advising its shareholders of the availability on the Internet of the proxy materials relating to the Meeting. These rules allow companies to provide access to proxy materials in one of two ways. Because the Fund has elected to utilize the “full set delivery” option, the Fund is delivering to all shareholders paper copies of all of the proxy materials, as well as providing access to those proxy materials on a publicly accessible website.
In order that your Shares may be represented at the Meeting, you are requested to:
—indicate your instructions on the Proxy;
—date and sign the Proxy;
—mail the Proxy promptly in the enclosed envelope; and
—allow sufficient time for the Proxy to be received and processed on or before 2:00 p.m. Eastern Time on April22, 2025.
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders of the Fund to Be Held on Tuesday, April22, 2025. The Notice of Annual Meeting of Shareholders, Proxy Statement and the Fund’s most recent annual report are available on the Internet at www.credit-suisse.com/us. The Fund will furnish, without charge, a copy of the Fund’s annual report for fiscal year ended December31, 2024 to any Fund shareholder upon request. To request a copy, please write to the Fund c/o UBS Asset Management (Americas) LLC, Eleven Madison Avenue, 9th Floor, New York, NY 10010, or call Telephone: 1-800-293-1232. You may also call for information on how to obtain to be able to attend the Meeting and vote virtually.
PROPOSAL 1: ELECTION OF DIRECTORS
The only proposal to be submitted at the Meeting will be the election of three(3)Non-Interested Directors (as defined below) of the Fund to hold office for the term set forth below and until their respective successors are duly elected and qualified. Directors who are not “interested persons” (as that term is defined in Section2(a)(19) of the Investment Company Act of 1940, as amended (the “1940 Act”)) of the Fund and the Fund’s investment adviser, UBS AM (Americas), are
3
referred to in this Proxy Statement as “Non-Interested Directors”. “Interested persons” of a fund include, among others, persons who currently have or have had certain affiliations or relationships with the fund or its investment adviser or principal underwriter. Directors who are “interested persons” of the Fund and UBS AM (Americas) are referred to in this Proxy Statement as “Interested Directors.”
Pursuant to the Fund’s Articles of Incorporation, the Board is divided into three classes, with each class having a term of three years. Each year the term of one class will expire. Each of Laura A. DeFelice and Charles W. Gerber currently serves as a Director of the Fund and has been nominated to serve as a Class III Director for a three-year term to expire at the Fund’s 2028 Annual Meeting of Shareholders or until his or her successor is duly elected and qualified. LeeM.Shaiman is nominated to serve as a Class I Director for a one-year term to expire at the Fund’s 2026 Annual Meeting of Shareholders or until his successor is duly elected and qualified. Samantha Kappagoda currently serves as a ClassI Director for a three-year term to expire at the Fund’s 2026 Annual Meeting of Shareholders or until her successor is duly elected and qualified. Each of Mahendra R. Gupta and John G. Popp currently serves as a Class II Director for a three-year term to expire at the Fund’s 2027 Annual Meeting of Shareholders or until his successor is duly elected and qualified.
Each nominee has indicated an intention to continue to serve if elected and has also consented to being named in this Proxy Statement.
The following tables set forth certain information regarding the nominees for election to the Board, Directors whose terms of office continue beyond the Meeting, and the principal officers of the Fund.
4
DIRECTORS/NOMINEES
|
ALIGN="center" STYLE="border-bottom:1.00px solid #000000">
Name, Address, and Year of Birth |
Position(s)
Held With Fund |
Term of
|
Principal
|
Numberof
Portfolios in Fund Complex*** Overseen ByDirector |
Other
Nominees for Non-Interested Director:
Laura A. DeFelice
c/o UBS Asset Management (Americas) LLC
Attn: General Counsel
New York 10010
Year of
Birth: 1959
Charles W. Gerber
c/o UBS Asset Management (Americas) LLC
Atttn: General Counsel Eleven Madison Avenue, New York,
New York 10010
Year of
Birth: 1955
Director, MA Holdings, Inc. (real estate management) from 2023 to present.
Lee M. Shaiman
c/o UBS Asset Management (Americas) LLC
5
Name, Address, and
Year of Birth
Term of
Principal
Other
Non-Interested Directors:
Mahendra R. Gupta
c/o UBS Asset Managment (Americas)LLC
Attn: General Counsel Eleven Madison Avenue New York,
New York 10010
Year of
Birth: 1956
Professor, Washington University in St. Louis from 1990 to present; Partner, R.J. Mithaiwala (Food manufacturing and retail, India) from 1977
to present; Partner, F.F.B. Corporation (Agriculture, India) from 1977 to present; Partner, RPMG Research Corporation (Benchmark research) from 2001 to present.
Director of Caleres Inc. (footwear) from 2012 to present; Director and Chair of the finance committee at the Foundation of Barnes Jewish
Hospital (healthcare) from 2018 to present and 2024 to present, respectively; Director of First Bank (finance) from 2023 to present; Director of ENDI Corporation (finance) from 2023 to present; Director of Consortium for Graduate Study in Management
(non-profit) from 2017 to 2023; Director of The Oasis Institute (non-profit) from 2022 to present; Director of Koch Development Corporation (real estate development) from 2017 to 2020; Director of the Guardian Angels of St.Louis
(not-for-profit) from 2015 to 2021.
Samantha Kappagoda
c/o UBS Asset Management (Americas) LLC
Attn: General Counsel Eleven Madison Avenue New York,
New York 10010
Date of
Birth: 1968
6
Name, Address, and
Year of Birth
Term of
Principal
Other
Interested Director:
John G. Popp**
UBS Asset Management (Americas) LLC
Eleven Madison Avenue
New
York,
New York 10010
Year of Birth: 1956
Subject to the Fund’s retirement policy, no Director shall be presented to shareholders of the Fund for
election at any meeting that is scheduled to occur after he/she has reached the age of 74 and a Director shall automatically be deemed to retire from the Board at the next annual shareholders’ meeting following the date that he/she reaches the
age of 75 years even if his/her term of office has not expired on that date. The requirements of the retirement policy may be waived with respect to an individual Director. Each Officer serves until his or her respective successor has been duly
elected and qualified.
Mr. Popp is an “interested person” of the Fund as defined in the 1940 Act by virtue of his current
position as an officer of UBS AM (Americas).
The “Fund Complex” (or “Credit Suisse Funds”) consists of Credit Suisse High Yield Bond
Fund, Credit Suisse Asset Management Income Fund, Inc., Credit Suisse Commodity Strategy Funds (which currently consists of two portfolios), Credit Suisse Opportunity Funds (which currently consists of two portfolios) and Credit Suisse Trust (which
currently consists of one portfolio).
Mr. Gerber also serves on the advisory board of all of the open-end Credit Suisse Funds.
7
OFFICERS WHO ARE NOT DIRECTORS
Name, Address,
Principal Occupation(s)
Omar Tariq
UBS Asset Management (Americas) LLC
Eleven Madison Avenue
New
York,
New York 10010
Year of Birth: 1983
Brandi Sinkovich
UBS Asset Management (Americas) LLC
Eleven Madison Avenue
Year of Birth: 1979
Lou Anne McInnis
UBS Asset Management (Americas) LLC
Eleven Madison Avenue
New
York,
New York 10010
Year of Birth: 1959
Karen Regan
UBS Asset Management (Americas) LLC
Eleven Madison Avenue
New
York,
New York 10010
Year of Birth: 1963
8
Name, Address,
Principal Occupation(s)
Rose Ann Bubloski
UBS Asset Management (Americas) LLC
Eleven Madison Avenue
New
York
New York 10010
Year of Birth: 1968
The current terms of office of the Fund’s officers will end at the Board of Directors’ meeting next
following the Meeting, at which meeting it is anticipated that the Board will consider electing the Fund’s officers for an additional term.
Qualification of Board of Directors/Nominees
The Board believes that each Director’s and nominee’s experience, qualifications, attributes or skills on an individual basis and in
combination with those of the other Directors lead to the conclusion that each Director and nominee should serve as a Director. Among the attributes common to all Directors and the nominees are their ability to review critically, evaluate, question
and discuss information provided to them, to interact effectively with the other Directors, UBS AM (Americas), other service providers, counsel and the independent registered public accounting firm, and to exercise effective business judgment in the
performance of their duties as Directors. A Director’s or nominee’s ability to perform his or her duties effectively may have been attained through the Director’s or nominee’s business, consulting, public service and/or academic
positions; experience from service as a board member of the Fund and the other funds in the Fund Complex, other investment funds, public companies, or non-profit entities or other organizations; educational background or professional training;
and/or other life experiences. In addition to these shared characteristics, set forth below is a brief discussion of the specific experience, qualifications, attributes or skills of each Director and nominee that support the conclusion that each
person should serve as a Director.
Nominees for Non-Interested Director
Laura A. DeFelice.
Ms.DeFelice has been a Director of the Fund since 2018 and Chair of the Board since November 2023.
Ms.DeFelice is the founding principal of two companies, one focusing on multi-family and commercial real estate ownership, leasing and management and the other focusing on renewable energy project development.She has over 25 years of
business experience in the financial services industry, including as a law firm partner specializing in structured finance. Ms. DeFelice currently serves on the boards of directors/trustees of all of the open-end Credit Suisse Funds and another
closed-end fund in the Fund Complex.
9
Charles W. Gerber
. Mr. Gerber has been a Director of the Fund since 2024. Mr. Gerber
is a Consultant of Canadian Imperial Bank of Commerce, a Senior Adviser of Stoneturn Group, LLP, and a Director of Michael Anthony Holdings, Inc. He has over 30 years of experience in financial services and related legal, compliance and corporate
governance matters. Mr. Gerber also serves on the advisory committee of the boards of trustees of all of the open-end Credit Suisse Funds and on the board of directors of another closed-end fund in the Fund Complex.
Lee M. Shaiman
. Mr. Shaiman has been a Director of the Fund since 2024. Mr. Shaiman is a Director of Investcorp Credit Management BDC,
Inc., and Executive Director and Board Member of the Loan Syndications and Trading Association. He has 40 years of experience in the financial services industry as an investment banker, financial analyst, debt syndicate manager and portfolio
manager. Mr. Shaiman also serves on the boards of directors/trustees of all of the pen-end Credit Suisse Funds and another closed-end fund in the Fund Complex.
Non-Interested Directors
Mahendra R.
Gupta.
Mr. Gupta has been a Director of the Fund since 2018 and Chair of the Audit Committee since 2019. Mr. Gupta is a Professor at Washington University in St. Louis. He has over 30 years of academic experience as a professor of
accounting and management. Mr. Gupta currently also serves on the boards of directors/trustees of all the open-end Credit Suisse Funds and another closed-end fund in the Fund Complex.
Samantha Kappagoda.
Ms. Kappagoda has been a Director of the Fund and Chair of the Nominating Committee since 2023. Ms. Kappagoda is the
Chief Economist and
Co-Founder
of Risk Economics, Inc. and Co-Managing Member of Numerati Partners LLC. She has over 30 years of experience as an economist. Ms. Kappagoda currently also serves on the boards of
directors/trustees of all the open-end Credit Suisse Funds and another closed-end fund in the Fund Complex.
Interested Director
John G. Popp.
Mr.Popp has been a Director since 2013. Mr. Popp is the Chief Investment Officer of the Fund and another closed-end
fund in the Fund Complex. He is a Managing Director of UBS AM (Americas). He is the Global Head and Chief Investment Officer of the Credit Investments Group. Mr. Popp has been associated with UBS AM (Americas) and Credit Suisse since 1997. He has
over 30 years of business experience in the financial services industry. Mr.Popp also served as Chief Executive Officer and President of all the funds in the Credit Suisse Fund Complex from 2010 to 2024, and is a trustee of another closed-end
fund in the Fund Complex. Mr.Popp has been a trustee of all the open-end funds in the Fund Complex since 2017.
Specific details
regarding each Director’s and nominee’s principal occupations during the past five years are included in the table above.
10
Set forth in the table below is the dollar range of equity securities in the Fund and the
aggregate dollar range of equity securities in the Credit Suisse Family of Investment Companies (as defined below) beneficially owned by each Director or nominee.
Name of Director or Nominee
Nominees for Non-Interested Director:
Laura A. DeFelice
Charles W. Gerber
Non-Interested Directors:
Mahendra R. Gupta
Samantha Kappagoda
Interested Director:
John G. Popp
Key to Dollar Ranges
None
$1 - $10,000
$10,001 - $50,000
$50,001 - $100,000
over $100,000
This information has been furnished by each Director as of February 28, 2025. “Beneficial Ownership”
is determined in accordance with Rule 16a-1(a)(2) promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”).
The Fund’s Directors and officers, in the aggregate, own less than 1% of the Fund’s outstanding equity
securities.
“Credit Suisse Family of Investment Companies” means those registered investment companies that share
Credit Suisse as their investment adviser and that hold themselves out to investors as related companies for purposes of investment and investor services.
As of February 28, 2025, none of the nominees for election to the Board as Non-Interested Directors, the other Non-Interested Directors or
their immediate family members owned beneficially or of record any class of securities in Credit Suisse or in a person (other than a registered investment company) directly or indirectly controlling, controlled by or under common control with Credit
Suisse.
During the fiscal year ended December31, 2024, each Non-Interested Director received an annual fee of $23,100 and $2,100 for
each meeting of the Board attended by him or her and was reimbursed for expenses incurred in connection with his or her attendance at the Fund’s Board meetings. The total remuneration paid by the Fund during the fiscal year ended
December31, 2024 to all such Non-Interested Directors was $194,244. During the fiscal year ended December 31, 2024, the Chair of the Board received an additional annual fee of $4,764 and the
11
Audit Committee Chair received an additional annual fee of $2,609. The Nominating Committee Chair received an additional annual fee of $1,072. Effective January 1, 2025, each Director will
receive an annual retainer of $70,560 for four quarterly meetings and one special meeting.
During the fiscal year ended December31,
2024, the Board convened nine times. Each Director attended at least seventy-five percent of the aggregate number of meetings of the Board and any committees on which he or she served during the period for which he or she was a Director.
Leadership Structure and Oversight Responsibilities
Overall responsibility for oversight of the Fund rests with the Board. The Fund has engaged UBS AM (Americas) to manage the Fund on a
day-to-day basis. The Board is responsible for overseeing UBS AM (Americas) and other service providers in the operations of the Fund in accordance with the provisions of the 1940 Act, applicable provisions of state and other laws and the
Fund’s charter. The Board is currently composed of six members each of whom, other than Mr.Popp, is a Non-Interested Director. The Board meets at regularly scheduled quarterly meetings each year. In addition, the Board may hold special
meetings or informal conference calls to discuss specific matters that may arise or require action between regular meetings. As described below, the Board has established a Nominating Committee and an Audit Committee, and may establish ad hoc
committees or working groups from time to time, to assist the Board in fulfilling its oversight responsibilities. The Non-Interested Directors have also engaged independent legal counsel to assist them in performing their oversight responsibilities.
The Board has appointed Laura A. DeFelice, a Non-Interested Director, to serve in the role of Chair. The Chair’s role is to preside
at all meetings of the Board and to act as a liaison with UBS AM (Americas), counsel and other Directors generally between meetings. The Chair serves as a key point person for dealings between management and the Directors. The Chair may also perform
such other functions as may be delegated by the Board from time to time. The Board reviews matters related to its leadership structure annually. The Board has determined that the Board’s leadership structure is appropriate because it allows the
Board to exercise informed and independent judgment over the matters under its purview and it allocates areas of responsibility among committees of Directors and the full Board in a manner that enhances effective oversight.
The Fund is subject to a number of risks, including investment, compliance, operational and valuation risks, among others. Risk oversight forms
part of the Board’s general oversight of the Fund and is addressed as part of various Board and committee activities. Day-to-day risk management functions are subsumed within the responsibilities of UBS AM (Americas) and other service providers
(depending on the nature of the risk), which carry out the Fund’s investment management and business affairs. UBS AM (Americas) and other service providers employ a variety of processes, procedures and controls to identify various events or
circumstances that give rise to risks, to lessen the probability of their occurrence and/or to
12
mitigate the effects of such events or circumstances if they do occur. Each of UBS AM (Americas) and other service providers has their own independent interest in risk management, and their
policies and methods of risk management will depend on their functions and business models. The Board recognizes that it is not possible to identify all of the risks that may affect the Fund or to develop processes and controls to eliminate or
mitigate their occurrence or effects. As part of its regular oversight of the Fund, the Board interacts with and reviews reports from, among others, UBS AM (Americas), the Fund’s Chief Compliance Officer, the Fund’s independent registered
public accounting firm and counsel, as appropriate, regarding risks faced by the Fund and applicable risk controls. The Board may, at any time and in its discretion, change the manner in which it conducts risk oversight.
All of the Directors, except for John Popp, constitute the Fund’s Audit Committee, which is composed of Directors who are not interested
persons of the Fund and who are independent (as such term is defined by the listing standards of the NYSE American, LLC, formerly known as NYSE MKT, LLC (the “NYSE American”)). The Audit Committee convened five times during the fiscal year
ended December31, 2024. The Audit Committee advises the full Board with respect to accounting, auditing and financial matters affecting the Fund.
All of the Directors, except for John Popp, constitute the Fund’s Nominating Committee, which is composed of Directors who are not
interested persons of the Fund and who are independent (as such term is defined by the listing standards of the NYSE American). The Nominating Committee met four times during the fiscal year ended December31, 2024. At a meeting of the
Nominating Committee held on February 11, 2025, the Nominating Committee (with the nominees abstaining from voting) determined to recommend to the full Board the nomination of each of LauraA. DeFelice and Charles W. Gerber for a three-year
term and LeeM.Shaiman for a one-year term. The Nominating Committee selects and recommends to the full Board candidates for nomination as Directors. The Board has adopted a Nominating Committee Charter (a copy of which was included as
Appendix A to the Fund’s Proxy statement dated March 20, 2024). In nominating candidates, the Nominating Committee will take into consideration such factors as it deems appropriate. These factors may include judgment, skill, diversity,
experience with investment companies and other organizations of comparable purpose, complexity, size and subject to similar legal restrictions and oversight, the interplay of the candidate’s experience with the experience of other Board
members, and the extent to which the candidate would be a desirable addition to the Board and any committees thereof. With respect to diversity, the Nominating Committee considers whether a candidate’s background, experience and skills will
contribute to the diversity of the Board.
The Nominating Committee will consider candidates submitted by shareholders or from other
sources it deems appropriate. Any recommendation should be submitted to the Secretary of the Fund, c/o UBS Asset Management (Americas) LLC, Eleven Madison Avenue, 9th Floor, New York, New York 10010. Shareholders or shareholder groups submitting
proposed candidates must substantiate compliance with the
13
requirements in the Fund’s
By-laws
at the time of submitting their proposed candidate. Any submission should include, at a minimum, the following
information: As to each individual proposed for election or
re-election
as director, the name, age, business address, residence address and principal occupation or employment of such individual, the class,
series and number of shares of stock of the Fund that are beneficially owned by such individual, the date such shares were acquired and the investment intent of such acquisition, whether such shareholder believes such individual is, or is not, an
“interested person” of the Fund (as defined in the 1940 Act), and information regarding such individual that is sufficient, in the discretion of the Nominating Committee, to make such determination, and all other information relating to
such individual that is required to be disclosed in solicitation of proxies for election of directors in an election contest (even if an election contest is not involved) or is otherwise required, in each case pursuant to Regulation 14A (or any
successor provision) under the 1934 Act, and the rules thereunder (including such individual’s written consent to being named in the proxy statement as a nominee and to serving as a director (if elected)). To be considered for inclusion in the
Fund’s proxy statement, the submission must be delivered to or mailed and received at the principal executive offices of the Fund not later than 120 days, nor earlier than 150 days, before the first anniversary of the date on which the Fund
first mailed its proxy materials for the annual meeting held in the prior year; provided, however, that in the event that the date of the annual meeting is advanced or delayed by more than 30 days from the first anniversary of the preceding
year’s annual meeting, notice by such shareholder to be timely must be so received not earlier than 150 days prior to such annual meeting and not later than the close of business on the 10th day following the day on which notice or public
announcement of the date of such meeting was given or made. Any such submission must also be submitted by such date and contain such information as may be specified in the Fund’s
By-laws,
or as required
by any relevant stock exchange listing standards.
The Fund does not have a Compensation Committee.
14
COMPENSATION
The following table shows certain compensation information for the Directors for the fiscal year ended December31, 2024. All officers of
the Fund are employees of and are compensated by UBS AM (Americas). None of the Fund’s executive officers or Directors who are also officers or directors of UBS AM (Americas) received any compensation from the Fund for such period. The Fund has
no bonus, profit sharing, pension or retirement plans.
Name of Director or Nominee
Nominees for Non-Interested Director:
Laura A. DeFelice
Charles W. Gerber***
Lee M. Shaiman***
Non-Interested Directors:
Mahendra Gupta
Samantha Kappagoda
Steven N. Rappaport**
7 funds comprise the Fund Complex and each Director serves as a director/trustee on the board of each fund in
the Fund Complex.
Mr. Rappaport retired as a Director effective December 31, 2024.
Messrs. Gerber and Shaiman were each appointed as a Director of the Fund effective August 13, 2024.
Recommendation of the Board of Directors
The Board unanimously recommends a vote “FOR” the election of the nominees to the Board.
OTHER BOARD-RELATED MATTERS
Shareholders who wish to send communications to the Board should send them to the address of the Fund and to the attention of the Board c/o the
Secretary of the Fund. All such communications will be directed to the Board’s attention.
The Fund does not have a formal policy
regarding Board member attendance at the Annual Meeting of Shareholders.
REPORT OF THE AUDIT COMMITTEE
Pursuant to the Audit Committee Charter adopted by the Board (a copy of which was included as Appendix B to the Fund’s Proxy statement
dated March 20, 2024), the Audit Committee is responsible for conferring with the Fund’s independent registered public accounting firm, reviewing annual financial statements, approving the selection of the Fund’s independent registered
public accounting firm and overseeing the Fund’s internal controls. The Fund’s Audit Committee charter also contains provisions relating to the pre-approval by the Audit Committee of certain non-audit
15
services to be provided by the independent registered public accounting firm to the Fund and to Credit Suisse and certain of its affiliates. The Audit Committee advises the full Board with
respect to accounting, auditing and financial matters affecting the Fund. The independent registered public accounting firm is responsible for planning and carrying out audits in accordance with standards established by the Public Company Accounting
Oversight Board (United States) (“PCAOB”).
The Audit Committee has met with the Fund’s management to discuss, among other
things, the Fund’s audited financial statements for the fiscal year ended December31, 2024. The Audit Committee has also met with the Fund’s independent registered public accounting firm, Ernst Young LLP (“EY”), and
discussed with them certain matters required to be discussed by the applicable requirements of the PCAOB and the SEC. The Audit Committee has received from EY the letter required by the SEC’s independence rules describing any relationships
between it and the Fund, UBS AM (Americas) and its affiliates that may be thought to bear upon the independence of the independent registered public accounting firm. The Audit Committee has discussed with EY its independence and has considered
whether the provision of services by EY to the Fund, UBS AM (Americas) and its affiliates was compatible with maintaining EY’s independence.
The members of the Audit Committee are not professionally engaged in the practice of auditing or accounting and are not employed by the Fund
for accounting, financial management or internal control. Moreover, the Audit Committee relies on and makes no independent verification of the facts presented to it or representations made by management or the independent registered public
accounting firm. Accordingly, the Audit Committee’s oversight does not provide an independent basis to determine that management has maintained appropriate accounting and financial reporting principles and policies, or internal controls and
procedures, designed to assure compliance with accounting standards and applicable laws and regulations. Furthermore, the Audit Committee’s considerations and discussions referred to above do not provide assurance that the audit of the
Fund’s financial statements has been carried out in accordance with generally accepted auditing standards or that the financial statements are presented in accordance with generally accepted accounting principles.
Based upon these reviews and discussions, the Audit Committee recommended to the Board that the Fund’s audited financial statements be
included in the Fund’s 2024 Annual Report to Shareholders for the fiscal year ended December31, 2024 and be mailed to shareholders and filed with the SEC.
Submitted by the Audit Committee of the Fund’s Board of Directors
Laura A. DeFelice
Charles W.
Gerber
Mahendra R. Gupta
Samantha Kappagoda
Lee M. Shaiman
16
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
On April 23, 2024, the Fund’s Board approved the dismissal of PricewaterhouseCoopers LLP (“PwC”) as the independent registered public accounting
firm for the Fund, due to PwC’s ceasing to be deemed an independent registered public accounting firm with respect to the Fund after April 30, 2024. The Board’s decision to approve the dismissal of PwC was recommended by the Audit
Committee of the Board. PwC’s reports on the Fund’s financial statements for the fiscal periods ended December 31, 2023 and December 31, 2022 contained no adverse opinion or disclaimer of opinion nor were they qualified or modified as to
uncertainty, audit scope or accounting principle. During the Fund’s fiscal periods ended December31, 2023 and December 31, 2022 and the subsequent interim period through April23, 2024, (i) there were no disagreements with PwC on any
matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of PwC, would have caused them to make reference to the subject matter of the
disagreements in connection with their reports on the Fund’s financial statements for such periods, and (ii) there were no “reportable events” of the kind described in Item304(a)(1)(v) of Regulation S-K under the Securities
Exchange Act of 1934, as amended.
Effective June 19, 2024, Ernst Young LLP (“EY”) was engaged as the independent
registered public accounting firm following the recommendation of the Audit Committee of the Fund’s Board and approval by the Fund’s Board for the fiscal year ending December 31, 2024. During the Fund’s fiscal periods ended December
31, 2023 and December 31, 2022 and the subsequent interim period through June 19, 2024, neither the Fund, nor anyone on its behalf, consulted with EY on items which: (i) concerned the application of accounting principles to a specified transaction,
either completed or proposed, or the type of audit opinion that might be rendered on the Fund’s financial statements; or (ii) concerned the subject of a disagreement (as defined in paragraph (a)(1)(iv) of Item 304 of Regulation S-K) or
reportable events (as described in paragraph (a)(1)(v) of said Item304).
At a meeting held on April 23, 2024, the Fund’s Audit
Committee approved the selection of as the Fund’s independent registered public accounting firm for the fiscal year ending December 31, 2024, EY has been the Fund’s independent registered public accounting firm since June 19, 2024, and has
informed the Fund that it has no material direct or indirect financial interest in the Fund. A representative of EY will be available by telephone at the Meeting and will have the opportunity to make a statement, if the representatives so desire,
and will be available to answer any questions that may arise.
The information in the table below is provided for services rendered to the
Fund showing the amount of fees billed to the Fund during the Fund’s last two fiscal years by PwC and EY. For engagement with PwC and EY, the Audit Committee approved in advance all audit services and non-audit services that PwC
17
provided to the Fund for its fiscal year ended December 31, 2023 and that EY provided to the Fund for its fiscal year ended December31, 2024.
Audit Fees
Audit-Related Fees
Tax Fees
(1)
All Other Fees
(2)
Total
Tax services in connection with the Fund’s excise tax calculations and review of the Fund’s applicable
tax returns.
Represents payments to PwC for the issuance of a consent letter and comfort letter in connection with the
Fund’s registration statement on Form N-2 and prospectus supplement.
The Audit Committee is responsible for
pre-approving (i)all audit and permissible non-audit services to be provided by the independent registered public accounting firm to the Fund and (ii)all permissible non-audit services to be provided by the independent registered public
accounting firm to UBS AM (Americas) and any service provider to the Fund controlling, controlled by or under common control with UBS AM (Americas) that provided ongoing services to the Fund (each a “Covered Services Provider”) if the
engagement relates directly to the operations and financial reporting of the Fund. The Audit Committee may delegate its responsibility to pre-approve any such audit and permissible non-audit services to the Chairperson of the Audit Committee, and
the Chairperson shall report to the Audit Committee, at its next regularly scheduled meeting after the Chairperson’s pre-approval of such services, his or her decision(s). The Audit Committee may also establish detailed pre-approval policies
and procedures for pre-approval of such services in accordance with applicable laws, including the delegation of some or all of the Audit Committee’s pre-approval responsibilities to other persons (other than UBS AM (Americas) or the
Fund’s officers). Pre-approval by the Audit Committee of any permissible non-audit services shall not be required so long as: (i)the aggregate amount of all such permissible non-audit services provided to the Fund, UBS AM (Americas) and
any Covered Services Provider constitutes not more than 5% of the total amount of revenues paid by the Fund to its independent registered public accounting firm during the fiscal year in which the permissible non-audit services are provided;
(ii)the permissible non-audit services were not recognized by the Fund at the time of the engagement to be non-audit services; and (iii)such services are promptly brought to the attention of the Audit Committee and approved by the Audit
Committee (or its delegate(s)) prior to the completion of the audit.
The aggregate fees billed for the fiscal years ended December 31,
2023 by PwC and December 31, 2024 by EY for non-audit services rendered to the Fund, UBS AM (Americas) or Covered Service Providers were $34,500 and $0, respectively.
All of the services described above were pre-approved by the Audit Committee.
18
ADDITIONAL INFORMATION
Beneficial Owners
Based upon the
Fund’s review of filings made pursuant to Section13 of the 1934 Act, as of February 28, 2025, to the Fund’s knowledge the following shareholders beneficially owned over 5% of the Fund’s Shares:
Common Stock
As stated in Schedule 13G/A filed with the SEC on January17, 2025, First Trust Portfolios L.P., First
Trust Advisors L.P. and the Charger Corporation share beneficial ownership of 12,173,294 Shares, or 22.21% of the common stock.
Delinquent Section 16(a) Reports
Section16(a) of the 1934 Act and Section30(h) of the 1940 Act require the Fund’s officers and directors, certain officers and
directors of the investment adviser, affiliated persons of the investment adviser, and persons who beneficially own more than 10% of the Fund’s Shares to file reports of ownership with the SEC and the Fund.
Based solely upon its review of the copies of such forms and amendments thereto filed electronically with the SEC during the fiscal year ended
December31, 2024 received by it and written representations from such persons, to the knowledge of the Fund, for the fiscal year ended December31, 2024, such reports were filed on a timely basis.
SHAREHOLDER PROPOSALS
Notice is hereby given that for a shareholder proposal to be considered for inclusion in the Fund’s proxy materials relating to its 2026
annual meeting of shareholders, pursuant to Rule
14a-8
under the 1934 Act, the shareholder must deliver the proposal to the offices of the Fund by November20, 2025. In the event the Fund moves the date
of its 2026 annual shareholder meeting by more than 30 days from the anniversary of its 2025 annual shareholder meeting, shareholder submissions of proposals for inclusion in the Fund’s proxy statement and proxy card for the 2026 annual
shareholder meeting pursuant to Rule 14a-8 under the Exchange Act must be delivered to the Fund at a reasonable time before the Fund begins to print and send its proxy materials in connection with the 2026 annual shareholder meeting. Under
Rule14a-8,
a shareholder proposal, including any accompanying supporting statement, may not exceed 500 words. Additionally, a shareholder desiring to submit a proposal must be: (i) a record or beneficial owner
of Shares with a market value of at least $2,000 and must have held such Shares for at least three years, (ii) a record or beneficial owner of Shares with a market value of at least $15,000 and must have held such Shares for at least two years, or
(iii) a record or beneficial owner of Shares with a market value of at least $25,000 and must have held such Shares for at least
19
one year. Further, the shareholder must continue to hold such Shares through the date on which the meeting is held. Documentary support regarding the foregoing must be provided along with the
proposal. There are additional requirements regarding proposals of shareholders, and a shareholder contemplating submission of a proposal is referred to Rule
14a-8
promulgated under the 1934 Act. The timely
submission of a proposal does not guarantee its inclusion in the Fund’s proxy materials.
Shareholders who do not wish to submit a
proposal for inclusion in the Fund’s proxy materials relating to its 2026 annual meeting of shareholders pursuant to
Rule14a-8
under the 1934 Act may submit a proposal to be considered for inclusion
in the Fund’s proxy materials relating to its 2026 annual meeting of shareholders in accordance with the Fund’s By-laws. Such shareholder proposal must be received by the Fund no earlier than October21, 2025 and no later than
November20, 2025, assuming that the 2026 annual meeting of shareholders is held within 30 days of April 22, 2026.
Pursuant to the
By-laws
of the Fund, at any annual meeting of the shareholders, only such business will be conducted as has been properly brought before the annual meeting. To be properly brought before the annual meeting, the
business must be (i)specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board, (ii)otherwise properly brought before the meeting by or at the direction of the Board, or (iii)otherwise
properly brought before the meeting by a shareholder in compliance with the requirements in the Fund’s
By-laws.
For business to be properly brought before the annual meeting by a shareholder, the shareholder must have given timely notice thereof in
writing to the Secretary of the Fund. To be timely, any such notice must be delivered to, or mailed (by certified mail being recommended) to and received by, Credit Asset Management Income Fund, Inc. c/o UBS Asset Management (Americas) LLC, Eleven
Madison Avenue, 9th Floor, New York, New York 10010 not later than 120 days, nor earlier than 150 days, before the first anniversary of the date on which the Fund first mailed its proxy materials for the annual meeting held in the prior year;
provided, however, that in the event that the date of the annual meeting is advanced or delayed by more than 30 days from the first anniversary of the preceding year’s annual meeting, notice by such shareholder to be timely must be so received
not earlier than 150 days prior to such annual meeting and not later than the close of business on the 10
th
day following the day on which notice or public announcement of the date of such meeting
was given or made. In no event shall the public announcement of an adjournment of an annual meeting commence a new time period for the giving of a shareholder’s notice as described above.
Any such notice by a shareholder shall set forth:
(i) as to any business that the shareholder proposes to bring before the annual meeting, a brief description of the business desired to
be brought before the annual meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration), the reasons for conducting such business at the annual meeting and any material interest in such business
of such shareholder and the beneficial owner, if any, on whose behalf the proposal is made; and
20
(ii) as to the shareholder giving the notice and the beneficial owner, if any, on
whose behalf the proposal is made:
(1) the name and address of such shareholder, as they appear on the Fund’s books, and of
such beneficial owner,
(2) the class and number of shares which are owned beneficially and of record by such shareholder and such
beneficial owner and any Person
1
who has a Disclosable Relationship
2
with such shareholder or beneficial owner (“Shareholder
Associate”),
(3) the name of each nominee holder of shares owned beneficially but not of record by such shareholder and such
beneficial owner and their respective Shareholder Associates, and the number of such shares held by each such nominee holder,
(4) a
description of any agreement, arrangement or understanding (whether written or oral) with respect to the proposal between or among such shareholder and such beneficial owner, any of their respective Shareholder Associates, and any other Person or
Persons (including their names) in connection with the proposal of such business and any material interest of such Person or any Shareholder Associate of such Person, insuch business, including any anticipated benefit therefrom to such Person,
or any Shareholder Associate of such Person,
1
”Person” means an individual, a corporation, a partnership, a limited liability company, an association, a trust or any other entity or organization, includ-ing a series or portfolio
of any of the foregoing, or a government or political sub-division or an agency or instrumentality thereof.
2
“Disclosable Relationship” with respect to another Person means (A)the existence at any time during the current calendar year or at any time within the two most recently
completed calendar years of any agreement, arrangement, understanding (whether written or oral) or practice, including sharing of information, decisions or actions, of a Person with such other Person with respect to the Fund or shares of the Fund,
(B)the beneficial ownership of securities of any Person known by such Person to beneficially own shares of the Fund and of which such Person knows such other Person also beneficially owns any securities, (C)sharing beneficial ownership
of any securities with such other Person, (D)being an immediate family member of such other Person, (E)the existence at any time during the current calendar year or at any time within the two most recently completed calendar years of a
material business or professional relationship with such other Person or with any Person of which such other Person is a holder of 5% or more of the outstanding voting securities, officer, director, general partner, managing member or employee or
(F)controlling, being controlled by or being under common control with such other Person.
21
(5) a description of any agreement, arrangement or understanding, whether written or
oral (including any derivative or short positions, profit interests, options, warrants, stock appreciation or similar rights, hedging transactions, and borrowed or loaned shares), that has been entered into as of the date of the shareholder’s
notice by, or on behalf of, such shareholder and such beneficial owners or their respective Shareholder Associates, the effect or intent of which is to mitigate loss to, manage the risk of or benefit from Fund share price changes, or increase or
decrease the voting power of, such shareholder or such beneficial owner or their respective Shareholder Associates, with respect to shares of the Fund,
(6) a description of all commercial and professional relationships and transactions between or among such shareholder and such beneficial
owners or their respective Shareholder Associates, and any other Person or Persons known to such shareholder and such beneficial owners or their respective Shareholder Associates to have a material interest in the matter that is the subject of such
notice,
(7) the investment strategy or objective, if any, of such shareholder and such beneficial owners and their respective
Shareholder Associates that are not individuals, and a copy of the most recent prospectus, offering memorandum or similar document, if any, provided to investors or potential investors in such shareholder, beneficial owner and each such Shareholder
Associate,
(8) a representation that the shareholder is a holder of record of shares of the Fund entitled to vote at such meeting
and intends to appear in person or by proxy at the meeting to propose such business,
(9) a representation whether the shareholder or
the beneficial owner, if any, intends or is part of a group which intends (a)to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Fund’s outstanding shares required to approve or adopt the
proposal and/or (b)otherwise to solicit proxies from shareholders in support of such proposal, and
(10) any other information
relating to such shareholder and such beneficial owner that would be required to be disclosed in a proxy statement or other filing required to be made in connection with the solicitation of proxies by such shareholder or beneficial owner with
respect to the proposed business to be brought by such Shareholder or beneficial owner before the meeting pursuant to Section14 of the 1934 Act and the rules and regulations promulgated thereunder, whether or not the shareholder submitting the
notice intends to deliver a proxy statement or solicit proxies.
(iii) A shareholder providing notice of any business proposed to be
brought before a meeting of shareholders shall further update and supplement such notice, if necessary, so that the information provided or required to be
22
provided in such notice shall be true and correct as of the record date for determining the shareholders entitled to receive notice of the meeting of shareholders and such update and supplement
shall be received by the Secretary of the Fund at the principal executive offices of the Fund not later than 5 business days after the record date for determining the shareholders entitled to receive notice of the meeting of shareholders.
The foregoing notice requirements shall be deemed satisfied by a shareholder if the shareholder has notified the Fund of his, her or its
intention to present a proposal at a meeting in compliance with Rule
14a-8
promulgated under the 1934 Act and such shareholder’s proposal has been included in a proxy statement that has been prepared by
the Fund to solicit proxies for such meeting.
The Fund may exercise discretionary voting authority with respect to any shareholder
proposals for the 2026 annual meeting of shareholders not included in the proxy statement and form of proxy that are not submitted to the Fund within the time-frame indicated above. Even if timely notice is received, the Fund may exercise
discretionary voting authority in certain other circumstances. Discretionary voting authority is the ability to vote proxies that shareholders have executed and returned to the Fund on matters not specifically reflected on the form of proxy.
SHAREHOLDERS WHO DO NOT EXPECT TO BE PRESENT AT THE ANNUAL MEETING AND WHO WISH TO HAVE THEIR SHARES VOTED ARE REQUESTED TO DATE AND SIGN THE ENCLOSED
PROXY CARD AND RETURN IT IN THE ENCLOSED ENVELOPE. NO POSTAGE IS REQUIRED IF MAILED IN THE UNITED STATES.
Delivery of Proxy
Only one copy of this Proxy Statement may be mailed to households, even if more than one person in a household is a shareholder of record. If a
shareholder needs an additional copy of this Proxy Statement, please contact the Fund at (800)293-1232. If any shareholder does not want the mailing of this Proxy Statement to be combined with those for other members of your household, please
contact the Fund in writing at: Eleven Madison Avenue, 9th Floor, New York, NewYork 10010 or call the Fund at (800)293-1232.
Other Business
Management knows of no business to be presented at the Meeting, other than the matters set forth in this Proxy Statement, but should
any other matter requiring the vote of shareholders arise, the proxies will vote thereon according to their best judgment in the interests of the Fund.
23
CREDIT SUISSE
ASSET MANAGEMENT INCOME FUND, INC.
April22, 2025
ANNUAL MEETING PROXY CARD
Credit Suisse Asset Management Income Fund, Inc,
Eleven Madison Avenue
New York, NY
10010
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF
CREDIT SUISSE ASSET MANAGEMENT INCOME FUND, INC.
The undersigned hereby appoints Omar Tariq and Karen Regan, each with the full power of substitution, and hereby authorizes them to represent and vote, as
designated below and in accordance with their judgment on such other matters as may properly come before the meeting or any adjournments thereof, all shares of Credit Suisse Asset Management Income Fund, Inc. (the “Fund”) that the
undersigned is entitled to vote at the annual meeting of shareholders of the Fund to be held at the offices of UBS Asset Management (Americas) LLC, Eleven Madison Avenue (between East 24th and 25th Streets), Floor 2B, New York, NY 10010, on
April22, 2025 at 2:00 p.m. Eastern time.
This proxy when properly executed will be voted in the manner directed therein by the undersigned
shareholder. If no direction is made, this proxy will be voted as recommended by the Board of Directors in favor of the Board’s nominees for Director named below.
In their discretion, the proxies are authorized to vote upon such other business as may properly be presented to the meeting or any adjournments,
postponements, continuations, or reschedulings thereof.
p
PLEASE FOLD
HERE
p
PLEASE VOTE, DATE AND SIGN BELOW AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.
TO VOTE, MARK ONE BOX IN BLUE OR BLACK INK. Example: ⬛
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR ALL THE NOMINEES LISTED.
Laura A. DeFelice and Charles W. Gerber are each being nominated to serve a three-year term and Lee M. Shaiman is being
nominated to serve a
one-year
term.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
